Enfusion (ENFN) Form 3/A Enfusion / Oleg Movchan ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Movchan Oleg

(Last) (First) (Middle)

C/O ENFUSION, INC.

125 SOUTH CLARK STREET SUITE 750

(Street)

CHICAGO IL 60603

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/21/2021

3. Issuer Name and Ticker or Trading Symbol
Enfusion, Inc. [ ENFN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)
10/21/2021

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Units of Enfusion Ltd. LLC(1)	(1)	(1)	Class A Common Stock	15,843,613	(1)	I	See Footnote(2)

1. Name and Address of Reporting Person^*

Movchan Oleg

(Last) (First) (Middle)

C/O ENFUSION, INC.

125 SOUTH CLARK STREET SUITE 750

(Street)

CHICAGO IL 60603

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

CSL Tech Holdings LLC

(Last) (First) (Middle)

C/O ENFUSION, INC.

125 SOUTH CLARK STREET SUITE 750

(Street)

CHICAGO IL 60603

(City) (State) (Zip)

Explanation of Responses:

1. Common Units of Enfusion Ltd. LLC, and the corresponding shares of Class B common stock, are exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis with the Issuer having the ability to elect to pay cash in lieu of issuing Class A common stock.

2. These Common Units are held by CSL Tech Holdings, LLC. Oleg Movchan is the sole manager of CSL Tech Holdings, LLC. Mr. Movchan may be deemed to have dispositive voting power over the Common Units held by CSL Tech Holdings, LLC. Mr. Movchan disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Remarks:

Exhibit 24.1 - Power of Attorney Exhibit 24.2 - Power of Attorney This amendment to Form 3 filed on 10/21/2021 is being filed to include CSL Tech Holdings, LLC as a Reporting Person.

	/s/ Blake Nielsen, as Attorney-in-Fact for Oleg Movchan	04/29/2022
	CSL Tech Holdings, LLC /s/ Blake Nielsen, as Attorney-in-Fact for CSL Tech Holdings, LLC Name: Blake Nielsen Title: Attorney-in-Fact	04/29/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.